OBJECTIVE: To estimate whether there is an association between length of gestation and gene polymorphisms that effect transcription of tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), or interleukin-1β (IL-1β). METHODS: Blood for DNA analysis was collected from 834 women at high risk enrolled in a randomized, clinical trial of omega-3 fatty acid supplementation for the prevention of recurrent preterm birth. Genotyping was performed for three single nucleotide polymorphisms (SNPs), TNF-α -308, IL-6 -174, and IL-1β +3954. Women with the homozygous minor genotype were compared with women with either the heterozygous or the homozygous major genotype. Kaplan-Meier curves of gestational age at delivery and odds ratios for extreme preterm delivery were adjusted for African-American race and treatment group. RESULTS: Women who were homozygous for the minor allele at the -308 position in the promoter region of the TNF-α gene had significantly shorter length of gestation than women who were either heterozygous or homozygous for the major allele (adjusted hazard ratio 1.74, 95% confidence interval [CI] 1.04-2.90, P=.03). Among women with this genotype, 20% (3/15) experienced extreme spontaneous preterm delivery (less than 28 weeks of gestation; adjusted odds ratio 7.51, 95% CI 1.84-30.72, P=.005). There was no difference in length of gestation or risk of extreme spontaneous preterm delivery by genotype for the IL-6 -174 or the IL-1β +3954 SNP. CONCLUSION: Polymorphism at the -308 position in the TNF-α promoter region is associated with shorter gestation and an increased risk of spontaneous extreme preterm delivery. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, www.clinicaltrials.gov, NCT00135902. LEVEL OF EVIDENCE: II.
RCT Entities:
OBJECTIVE: To estimate whether there is an association between length of gestation and gene polymorphisms that effect transcription of tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), or interleukin-1β (IL-1β). METHODS: Blood for DNA analysis was collected from 834 women at high risk enrolled in a randomized, clinical trial of omega-3 fatty acid supplementation for the prevention of recurrent preterm birth. Genotyping was performed for three single nucleotide polymorphisms (SNPs), TNF-α -308, IL-6 -174, and IL-1β +3954. Women with the homozygous minor genotype were compared with women with either the heterozygous or the homozygous major genotype. Kaplan-Meier curves of gestational age at delivery and odds ratios for extreme preterm delivery were adjusted for African-American race and treatment group. RESULTS:Women who were homozygous for the minor allele at the -308 position in the promoter region of the TNF-α gene had significantly shorter length of gestation than women who were either heterozygous or homozygous for the major allele (adjusted hazard ratio 1.74, 95% confidence interval [CI] 1.04-2.90, P=.03). Among women with this genotype, 20% (3/15) experienced extreme spontaneous preterm delivery (less than 28 weeks of gestation; adjusted odds ratio 7.51, 95% CI 1.84-30.72, P=.005). There was no difference in length of gestation or risk of extreme spontaneous preterm delivery by genotype for the IL-6 -174 or the IL-1β +3954 SNP. CONCLUSION: Polymorphism at the -308 position in the TNF-α promoter region is associated with shorter gestation and an increased risk of spontaneous extreme preterm delivery. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, www.clinicaltrials.gov, NCT00135902. LEVEL OF EVIDENCE: II.
Authors: John Attia; John P A Ioannidis; Ammarin Thakkinstian; Mark McEvoy; Rodney J Scott; Cosetta Minelli; John Thompson; Claire Infante-Rivard; Gordon Guyatt Journal: JAMA Date: 2009-01-14 Impact factor: 56.272
Authors: B M Mercer; R L Goldenberg; A H Moawad; P J Meis; J D Iams; A F Das; S N Caritis; M Miodovnik; M K Menard; G R Thurnau; M P Dombrowski; J M Roberts; D McNellis Journal: Am J Obstet Gynecol Date: 1999-11 Impact factor: 8.661
Authors: Margaret Harper; Elizabeth Thom; Mark A Klebanoff; John Thorp; Yoram Sorokin; Michael W Varner; Ronald J Wapner; Steve N Caritis; Jay D Iams; Marshall W Carpenter; Alan M Peaceman; Brian M Mercer; Anthony Sciscione; Dwight J Rouse; Susan M Ramin; Garland D Anderson Journal: Obstet Gynecol Date: 2010-02 Impact factor: 7.661
Authors: Tracy A Manuck; Gregory J Stoddard; Rebecca C Fry; M Sean Esplin; Michael W Varner Journal: Am J Obstet Gynecol Date: 2016-07-11 Impact factor: 8.661
Authors: Heather A Frey; Molly J Stout; Laurel N Pearson; Methodius G Tuuli; Alison G Cahill; Jerome F Strauss; Luis M Gomez; Samuel Parry; Jenifer E Allsworth; George A Macones Journal: Am J Obstet Gynecol Date: 2016-03-12 Impact factor: 8.661
Authors: Jennifer M Fettweis; Myrna G Serrano; Philippe H Girerd; Kimberly K Jefferson; Gregory A Buck Journal: Chem Biodivers Date: 2012-05 Impact factor: 2.408
Authors: Wilfred Wu; Erin A S Clark; Gregory J Stoddard; W Scott Watkins; M Sean Esplin; Tracy A Manuck; Jinchuan Xing; Michael W Varner; Lynn B Jorde Journal: BMC Genet Date: 2013-04-25 Impact factor: 2.797